KARACHI: Merck, a leading science and technology company, on Saturday announced it has successfully completed the sale of its shareholding in Pakistan to Martin Dow Ltd, creating one of the leading pharmaceutical groups in the country.

As previously announced, the companies would continue to be long-term strategic partners through licence agreements. This will allow the business in Pakistan to continue to have access to Merck’s healthcare and life science portfolios, thereby ensuring continued supply of its products to its patients and customers.

According to a press release, following the acquisition, the business in Pakistan will continue to operate as a separate legal entity, under the same organisational structure.

Martin Dow is committed to continuing and growing the existing business. The Marker family, the founder of the business, will remain a shareholder along with Martin Dow.

Financial terms of the deal were not disclosed.

Published in Dawn, December 11th, 2016

Opinion

Editorial

‘Source of terror’
29 Mar, 2024

‘Source of terror’

ALTHOUGH dealing with the presence of terrorist groups in Afghanistan is a major political, security and strategic...
Chipping in
29 Mar, 2024

Chipping in

FEDERAL infrastructure development schemes are located in the provinces. Most such projects — for instance,...
Toxic emitters
29 Mar, 2024

Toxic emitters

IT is concerning to note that dozens of industries have been violating environmental laws in and around Islamabad....
Judiciary’s SOS
Updated 28 Mar, 2024

Judiciary’s SOS

The ball is now in CJP Isa’s court, and he will feel pressure to take action.
Data protection
28 Mar, 2024

Data protection

WHAT do we want? Data protection laws. When do we want them? Immediately. Without delay, if we are to prevent ...
Selling humans
28 Mar, 2024

Selling humans

HUMAN traders feed off economic distress; they peddle promises of a better life to the impoverished who, mired in...